The coexistence of multiple and synchronous primary neoplasms in the same organ (including kidney) has only rarely been described in the literature. We herein present a case of collecting duct carcinoma (CDC) combined with papillary renal carcinoma (RCC) having a 57-month disease-free survival. CDC is a rather rare and aggressive neoplasm of the kidney. Sharing probably the same embryological origin, synchronous or metachronous association with in situ or papillary transitional cell carcinoma (TCC) may be found; association with RCC has been only once reported in the literature. The high incidence of c-erbB-2 oncogene amplification in CDC further characterizes this tumor as a separate entity from renal cell carcinoma, and shows some genetic characteristics in common with TCC. The histohgical diagnosis of Bellini CDC can be confirmed by the positive immuno-histochemical staining with a collecting duct marker and distal tubule marker and negative staining with a proximal tubule marker.

Synchronous collecting duct carcinoma and papillary renal cell carcinoma ; a case report and review of the litterature / D.V. Matei, B. Rocco, R. Varela, F. Verweij, E. Scardino, G. Renne, O. de Cobelli. - In: ANTICANCER RESEARCH. - ISSN 0250-7005. - 25:1B(2005 Jan), pp. 579-586.

Synchronous collecting duct carcinoma and papillary renal cell carcinoma ; a case report and review of the litterature

B. Rocco;O. de Cobelli
Ultimo
2005

Abstract

The coexistence of multiple and synchronous primary neoplasms in the same organ (including kidney) has only rarely been described in the literature. We herein present a case of collecting duct carcinoma (CDC) combined with papillary renal carcinoma (RCC) having a 57-month disease-free survival. CDC is a rather rare and aggressive neoplasm of the kidney. Sharing probably the same embryological origin, synchronous or metachronous association with in situ or papillary transitional cell carcinoma (TCC) may be found; association with RCC has been only once reported in the literature. The high incidence of c-erbB-2 oncogene amplification in CDC further characterizes this tumor as a separate entity from renal cell carcinoma, and shows some genetic characteristics in common with TCC. The histohgical diagnosis of Bellini CDC can be confirmed by the positive immuno-histochemical staining with a collecting duct marker and distal tubule marker and negative staining with a proximal tubule marker.
Papillary renal cell carcinoma; Synchronous collecting duct carcinoma
Settore MED/24 - Urologia
gen-2005
http://ar.iiarjournals.org/content/25/1B/579.full.pdf+html
Article (author)
File in questo prodotto:
File Dimensione Formato  
579.full.pdf

accesso aperto

Tipologia: Publisher's version/PDF
Dimensione 520.89 kB
Formato Adobe PDF
520.89 kB Adobe PDF Visualizza/Apri
Pubblicazioni consigliate

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/2434/45390
Citazioni
  • ???jsp.display-item.citation.pmc??? 8
  • Scopus 16
  • ???jsp.display-item.citation.isi??? 15
social impact